ArticleCirculation2017
Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.
Gissette Reyes-Soffer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
101 papers cite itlatest 60 shown
this paperpooled ittrialcites it